The female athlete triad exists in both elite athletes and controls.
OBJECTIVE
To examine the prevalence of the female athlete triad (the Triad) in Norwegian elite athletes and controls.


METHODS
This study was conducted in three phases: (part I) screening by means of a detailed questionnaire, (part II) measurement of bone mineral density (BMD), and (part III) clinical interview. In part I, all female elite athletes representing the national teams at junior or senior level, aged 13-39 yr (N = 938) and an age group-matched randomly selected population-based control group (N = 900) were invited to participate. The questionnaire was completed by 88% of the athletes and 70% of the controls. Based on data from part I, a stratified random sample of athletes (N = 300) and controls (N = 300) was selected and invited to participate in parts II and III of the study. 186 athletes (62%) and 145 controls (48%) participated in all parts of the study.


RESULTS
Eight athletes (4.3%) and five controls (3.4%) met all the criteria for the Triad (disordered eating/eating disorder, menstrual dysfunction, and low BMD). Six of the athletes who met all the Triad criteria competed in leanness sports, and two in nonleanness sports. When evaluating the presence of two of the components of the Triad, prevalence ranged from 5.4 to 26.9% in the athletes and from 12.4 to 15.2% in the controls.


CONCLUSIONS
Our results support the assumption that a significant proportion of female athletes suffer from the components of the Triad. In addition, we found that the Triad is also present in normal active females. Therefore, prevention of one or more of the Triad components should be geared towards all physically active girls and young women.
Torstveit
Monica Klungland
MK
The Norwegian University of Sport and Physical Education, Oslo. monica.torstveit@nih.no
Sundgot-Borgen
Jorunn
J
D015502:Absorptiometry, Photon; D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000568:Amenorrhea / Q000175:diagnosis / Q000453:epidemiology*; D015992:Body Mass Index; D015519:Bone Density; D016022:Case-Control Studies; D001068:Feeding and Eating Disorders / Q000175:diagnosis / Q000453:epidemiology*; D005260:Female; D006801:Humans; D007407:Interviews as Topic; D008019:Life Style; D008403:Mass Screening / Q000379:methods; D009043:Motor Activity; D009664:Norway / Q000453:epidemiology; D010024:Osteoporosis / Q000175:diagnosis / Q000453:epidemiology*; D015995:Prevalence; D018570:Risk Assessment; D013177:Sports / Q000706:statistics & numerical data*; D013577:Syndrome